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Abstract 
The effect of Hibiscus sabdariffa calyx extract on cisplatin-induced tissue damage was 
studied. A total of twenty rats were used for the study and split into four groups of five rats 
per group-group I, II, III, and IV. Tissue damage was induced in rats of groups II, III, and IV 
by a single intraperitoneal administration of cisplatin (5 mg/kg b.w.). Four days later, rats in 
groups III and IV were given 200 mg/kg b.w. and 300 mg/kg b.w respectively of the Hibiscus 
sabdariffa calyx extract once daily for another five days. Rats in group I were untreated 
controls. Tissue damage was later assessed in sera by measuring the levels of alanine 
aminotransferase, aspartate aminotransferase, urea, and creatinine. Thiobarbituric acid 
reactive species, catalase, and reduced glutathione levels were also measured in the livers and 
kidneys. The results reveal that the administration of cisplatin alone resulted to a significant 
increase in the levels of the serum markers over controls (p < 0.05). Cisplatin also caused a 
significant decrease in catalase activity, and also caused a significant reduction in the levels 
of reduced glutathione in the liver and kidney over controls (p < 0.05). Cisplatin also caused a 
significant increase in the levels of thiobarbituric acid reactive species in the liver (p < 0.05). 
All the markers assessed were brought to near control levels when the Hibiscus sabdariffa 
extract was given to the rats with the dose of 300 mg/kg b.w. possessing a higher activity. 
The results show that the Hibiscus sabdariffa extract ameliorated cisplatin-induced tissue 
damage in rats which may be dose-dependent. 
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The consumption of botanicals as 
complementary/ alternative medicine has been 
encouraged because they are relatively cheap 
and coupled with the belief that they could 
significantly contribute to the improvement of 
human health in terms of cure and the 
prevention of various human disorders in 
addition to the less frequent side effects 
reported when compared to modern medicine1. 
Among these botanicals of focus is Hibiscus 
sabdariffa Linn which is known as the Red 
Sorrel in English and the Zobo plant in 
Nigeria. Hibiscus sabdariffa Linn is an annual 
dicotyledonous herbaceous tropical plant that 
belongs to the family Malvaceae. The tender 
leaves of the plant are eaten as salad and 
curries traditionally and as a remedy for 
various ailments such as liver disorders, 
hypertension, pyrexia
2
, and as a diuretic, 
emollient, and purgative
3
. The infusions of the 
calyces have been shown to reduce intestinal 
transit, anti-inflammatory and anti-mutagenic 
effects4-6 among others. Duke and Atchley7 
revealed that the calyces of the plant (the 
principally utilized part) contain 14 mg 
ascorbate, 300 µg β-carotene, 1.9 g protein, 
12.3 g total carbohydrate, 2.7 mg Iron per 100 
g dry weight. In addition to these nutrients, 
various phytochemicals have also been 
identified in the calyces which include 
saponins, tannins, anthocyanins, cyanogenic 
glycosides, flavones, and polyphenols8,9. 
Despite these established bioactivities, it is a 
common belief that the plant is still 
underutilised as it is obvious that it could also 
possess other known activities due to the 
phytochemicals identified. Based of these, this 
work focused on the effect of the methanolic 
extract of the calyces of Hibiscus sabdariffa 
on cisplatin-induced oxidative damage in rat. 
Cisplatin (also called cisplatinum and 
carboplatin) is an anticancer drug but its 
cytotoxic potential is a major limiting factor of 
its chemotherapy as its use causes various 





MATERIALS AND METHODS 
 
Animals 
Twenty albino rats (Rattus novergicus) of both 
sexes (100-115 g) were purchased from the 
Nigerian Institute of Medical Research, Yaba, 
Lagos and kept in the animal housing facility 
of the Department of Biological Sciences of 
the Niger Delta University. They were allowed 
unlimited access to tap water and growers’ 
mash ad libitum housed in standard rat cages. 
 
Plant material and preparation of extract 
The calyces of matured Hibiscus sabdariffa 
were collected fresh from a garden and sun-
dried. The dried calyces were subsequently 
ground using a blender to fine powder. Five 
hundred grams of the powder was extracted 
using light petroleum in a soxhlet extractor for 
24 hours. A second extraction was made using 
80 % methanol and concentrated using a rotary 
evaporator at 400C and finally dried in a 
vacuum dessicator at 40
0
C. The resulting 
residue which weighed 8.13 g (recovery 
1.63%) was later stored under -40C until 
required. However, a 10 mg/ml solution of the 
extract was prepared in distilled water before 
administration to the rats. 
 
Treatment of animals  
The rats were split into four groups of five rats 
each after matching the weights. They were 
acclimatized to laboratory conditions for five 
days before commencement of treatment. 
Tissue damage was induced in rats of groups 
II, III, and IV by a single intraperitoneal-
administration of cisplatin (5 mg/kg body 
weight). Four days later, doses of 200 mg/kg 
b.w., and 300 mg/kg b.w. of the Hibiscus 
sabdariffa calyx extract was administered to 
rats in group III, and group IV respectively 
through the oral route using a gavage needle 
once daily for five days. Rats in group II were 
given sterile water in place of the Hibiscus 
sabdariffa extract. Rats in group I were 
untreated controls. They were all allowed 
unlimited access to tap water and growers’ 
mash. 
 
Collection of tissues 
Twenty four hours after the last administration 
of the extract, each rat was subjected to light 
anaesthesia in a urethane saturated chamber, 
and dissected. The thoracic region was 
exposed and blood was drawn through direct 
cardiac punctures and delivered into sample 
containers having no anticoagulant. Blood 
samples were allowed to clot for 20 minutes 
and centrifuged at 4000 rpm for 15 minutes. 
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Sera were collected using micropipettes and 
analysed. The livers and kidneys were also 
excised immediately and washed in cold 
saline. Ten percent tissue homogenates were 
prepared in phosphate buffer (0.05M, pH 
7.25). Perinuclear fractions were obtained after 
centrifuging homogenates at 1500 rpm for 20 
minutes using a centrifuge.  
 
Biochemical analysis 
Alanine aminotransferase (ALT) and aspartate 
aminotransferase (AST) were measured in sera 
as described11. Creatinine and urea were 
determined in serum by the modified Jaffe, 
and the modified Berthelot-Searcy enzymatic 
methods respectively using assay kits obtained 
from QCA Spain. Catalase in liver and kidney 
was measured in tissue homogenates following 
the method of Aebi12 with slight modifications. 
Briefly, 0.1 ml of perinuclear fraction was 
added to 1.5 ml of phosphate buffer (0.05M, 
pH 7.25), and 1.4 ml of distilled water. The 
reaction was initiated by the addition of 0.1 ml 
of 0.01M H2O2. Amount of H2O2 consumed 
was determined by measuring absorbance at 
240 nm after 30 s. The enzyme activity was 
expressed as k/g protein. Thiobarbituric acid 
reactive species (TBARS) were measured in 
the perinuclear fractions as reported13. 
Reduced glutathione (GSH) was also 
measured in the perinuclear fractions as 
previously described14.  
 
Statistical analysis 
Results of representative values were 
expressed as mean ± standard error of the 
mean (S.E.M). Comparisons between two 
groups were made using a two-tailed Student’s 






The levels of ALT, AST, creatinine and urea 
levels in sera are shown in Table 1. When the 
rats were treated with cisplatin alone, there 
was a significant increase in the levels of ALT, 
AST, creatinine and urea in group II over 
control rats (p < 0.05), while the levels of 
these markers in groups III, and IV were 
significantly reduced close to control levels 
after administration of the extract (p < 0.05), 
with group IV having the lowest values. Table 
2 shows the levels of GSH, catalase, and 
TBARS in the livers and kidneys of the rats.  
 
Table 1: Effect of pre-treatment with or without extract on some serum enzymes of 
hepatotoxicity, and non-enzymatic markers of kidney dysfunction 
Group ALT (U/L) AST  (U/L) Creatinine(mg/L) Urea (mg/L) 




























Values presented as the means ± S.E.M of readings from 5 individual rat sera (a significantly different 
from Group I;   b significantly different from group II; c significantly different from group III, p < 0.05) 
 
Table 2: Effect of pre-treatment with or without extract on the glutathione, catalase, and TBARS 









Liver     I 1.13±0.00 8.93±0.54 31.72±1.42 
          II 2.67±0.12a 6.26±0.07a 17.44±0.23a 
          III 1.25±0.01b 7.43±0.13ab 23.17±0.65ab 
         IV 1.23±0.14b 9.53±0.48bc 27.56±1.21abc 
Kidney    I 0.50±0.01 2.73±0.06 105.76±8.55 
             II 0.49±0.05 1.63±0.03a 68.12±3.28a 
         III 0.49±0.03 2.74±0.01b 87.35± 9.71ab 
IV  0.51±0.03 2.87±0.22b 93.58±7.76abc 
Values presented as the means ± S.E.M of readings from perinuclear fractions from homogenates from 5 
individual rat tissue (a significantly different from Group I; b significantly different from group II, c significantly 





When the rats were treated with only cisplatin, 
there was a significant reduction in the levels 
of GSH and catalase in both liver and kidney 
over controls (p < 0.05), while these reduced 
levels were increased close to control levels 
after the extract was given to the rats (p < 
0.05) with the group given the dose of 300 
mg/kg b.w. having the highest elevations. The 
level of TBARS in liver was significantly 
higher when the rats were treated with 
cisplatin alone (p < 0.05). However, the level 
of the marker was significantly reduced when 
the extract was administered to the rats (p < 
0.05). The levels of TBARS in the kidneys did 
not show any significant difference between 




Cisplatin is a cell cycle phase non-specific 
cytotoxic agent
15
 and it is this property that has 
been exploited in the treatment of various 
cancers. As with other drugs, its lack of 
specificity for neoplastic cells makes it 
seriously limiting. A major consequence is the 
reported nephrotoxicity and hepatotoxicity
16
. 
Though the toxicokinetics of cisplatin has not 
been fully known, lipid peroxidation may be 
involved in its adverse effects. The principal 
active metabolite is free filterable platinum
17
 
which has the propensity of adding to double 
bonds of membrane lipids, form adducts with 
proteins, DNA, and can also form stable 
products with other macromolecules. 
 
Chemotherapeutic levels known to induce 
mild kidney dysfunction in rats is thought to 
be a single dose of 5 mg/kg body weight 
which peaks about 3 – 5days
10,18
 thus the 
choice of a single dose of 5 mg/kg body 
weight, and the four days exposure before the 
administration of the extract for the present 
study. 
 
The increase in serum creatinine and urea 
levels in the rats after the intraperitoneal 
administration of cisplatin (group II) shows 
that cisplatin induced mild kidney dysfunction 
which is in accordance with previous studies19. 
This damage to the kidney was further 
experienced with the depletion in the levels of 
GSH and catalase in the kidney. 
 
The increase in the levels of ALT and AST in 
the sera of rats in group II also show that at 
that dose (5 mg/kg b.w.), cisplatin also 
damages the liver which was further evidenced 
by the elevated level of TBARS, and the 
reduction in the levels of GSH and catalase in 
the perinuclear fraction of the rat livers. The 
antioxidant enzyme catalase and GSH with 
other peroxidases constitute a supportive team 
against reactive oxygen species
20,21
 hence the 
depletion of GSH and catalase could enhance 
lipid peroxidation22. 
 
The reduction in the levels of TBARS, ALT, 
AST, and the elevation of catalase and GSH in 
the liver close to control levels in rats of 
groups III and IV clearly show that the 
Hibiscus sabdariffa extract reduced the liver 
damage induced by cisplatin. Also the 
reduction in the levels of serum creatinine, 
urea and the elevation of the levels of kidney 
GSH and catalase in rats of group III, and IV 
also indicate that the extract also reduced 
cisplatin induced kidney dysfunction. From the 
results, it was obvious that the bioactivity of 
the extract is dependent on the dose 
administered. The mechanism of this action is 
not fully understood. However, it could be 
suggested that the extract reduced the lipid 
peroxidation induced by cisplatin. It could also 
be suggested that the various phytochemicals 
inherent in the extract acted synergistically to 
sequester the free filterable platinum hence 
making it less available for cellular damage. 
The calyces of Hibiscus sabdariffa are rich in 
vitamin C, hence the reduction in the liver and 
kidney damages may be ascribed partly to this 
natural antioxidant which also functions in the 
conversion of α-tocopheroxy radical to α-




permeabilisation of renal cortex mitochondria 




permeabilisation of renal cortex mitochondria 
in cisplatin nephrotoxicity19. Anthocyanins are 
ubiquitous in the calyces of the plant thus this 
property of the extract may be attributed partly 
to these flavonoids which are known to be 
potent antioxidants and free radical 
scavengers25. 
 
Further work should focus on elucidating the 
actual protective mode of the extract. Since 
there are various phytochemicals in the 
calyces, proper fractionation of the extract 
should be done and each fraction subjected to 
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both in vitro and in vivo studies since some 
notable bioactivities of terpenes have also been 
reported25 in addition to the fact that 
flavonoids also possess pro-oxidant activities 
26
. Progress in this area will also extend the 
borders of even cisplatin chemotherapy. 
 
The occurrence of Hibiscus sabdariffa Linn in 
the biosphere is nature’s generosity in 
providing mankind with cheap and natural 
bioactive materials. Thus the exploitation of 
this natural gift in the production of 
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